MedTrace Logo

Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation

NCT01684735 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2023-01-31

No results posted yet for this study

Summary

Evaluation of the response to chemotherapy in breast cancer patients by the use of Diffusion-weighted magnetic resonance imaging of the breast before the start of chemotherapy, after one and 3 cycles of therapy and at the end of the therapy.

Conditions

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Chantal Van Ongeval, MD, Phd · Universitaire Ziekenhuizen KU Leuven

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684735 on ClinicalTrials.gov